Previous close | 230.15 |
Open | 232.00 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 230.80 - 246.50 |
52-week range | 230.80 - 246.50 |
Volume | |
Avg. volume | N/A |
Market cap | N/A |
Beta (5Y monthly) | 1.21 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
(Bloomberg) -- CVC Capital Partners and some of its investors are seeking to raise €1.6 billion ($1.7 billion) in an initial public offering in Amsterdam, as the buyout firm moves ahead with its long-delayed listing plans.Most Read from BloombergTrump Has Only $6.8 Million for Legal Fees With Trial UnderwayTikTok to Remove Executive Tasked With Fending Off US ClaimsChina Is Front and Center of Gold’s Record-Breaking RallyTesla Spends Weekend Cutting Prices of Cars and FSD SoftwareThe Fed’s Forec
Skincare company Galderma was on course to raise 2.3 billion ($2.6 billion) Swiss francs from its upcoming initial public (IPO) offering after a positive response from potential investors. The company, whose products includes Cetaphil, a product for damaged and sensitive skin, as well as fillers and skin creams, early on Wednesday announced a price range of 49 to 53 Swiss francs for its flotation - likely to be one of the biggest in Europe this year. The offering consists of up to 40.5 million new shares and 277,000 existing shares, the company said.